Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Cheng-Hsiang Lo"'
Autor:
Yi-Chiao Cheng, Kuen-Tze Lin, Wen-Yen Huang, Cheng-Hsiang Lo, Chun-Shu Lin, Jen-Fu Yang, Wei-Chou Chang, Hsing-Lung Chao
Publikováno v:
Journal of Medical Sciences.
Background: The aim of this study is to evaluate the outcomes and prognostic factors in patients with hepatocellular carcinoma (HCC) and Child–Turcotte–Pugh (CTP) class B liver function after stereotactic ablative radiotherapy (SABR). Materials a
Autor:
Yung-Liang Wan, Cheng-Hsiang Lo, Pei-Ching Huang, Hsian-He Hsu, Sung-Hua Chiu, Wen-Yen Huang, Yu-Lueng Shih, Wei-Chou Chang, Hsuan-Hwai Lin
Publikováno v:
Journal of Hepatocellular Carcinoma. 8:937-949
Drug-eluting beads transarterial chemoembolization (DEB-TACE) is an alternative to conventional lipiodol-based TACE (cTACE) to treat hepatocellular carcinoma (HCC). With the advancement in pharmacology, small-caliber DEB-TACE (
Autor:
Chun Shu Lin, Jeng Fong Chiou, Po Chien Shen, Yang Hong Dai, Wei Chou Chang, Shang Wen Chen, Chun You Chen, Jen Fu Yang, Wen Yen Huang, Jason Chia-Hsien Cheng, Hsin Lun Lee, Cheng-Hsiang Lo, Chih Weim Hsiang, Meei-Shyuan Lee
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:474-484
PURPOSE The objective of this study was to determine whether pretreatment neutrophil-to-lymphocyte ratio (NLR) could predict survival outcomes and liver toxicity in hepatocellular carcinoma (HCC) patients treated with stereotactic ablative radiation
Autor:
Yang-Hong Dai, Meei-Shyuan Lee, Cheng-Hsiang Lo, Jen-Fu Yang, Hsing-Lung Chao, Po-Chien Shen, Chun-Shu Lin, Wen-Yen Huang
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background This study aimed to compare the clinical outcomes of stereotactic ablative radiotherapy (SABR) and conventionally fractionated radiotherapy (CFRT) in hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI). Methods HCC pati
Autor:
Yang-Hong Dai, Chun-Shu Lin, Wen-Yen Huang, Po-Chien Shen, Jen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, Chao-Yueh Fan, Wei-Chou Chang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:307-318
This study compared the local control and overall survival (OS) between stereotactic body radiation therapy (SBRT) and transarterial chemoembolization (TACE) in medium-sized (3-8 cm) hepatocellular carcinoma (HCC).From January 2008 to October 2017, 1
Autor:
Cheng-Hsiang Lo, Wen-Yen Huang, Yang-Hong Dai, Chun-Shu Lin, Po-Chien Shen, Ying-Fu Wang, Wei-Chou Chang, Chih-Weim Hsiang, Jen-Fu Yang
Publikováno v:
Journal of Hepatocellular Carcinoma
Chih-Weim Hsiang,1 Wen-Yen Huang,2,3 Jen-Fu Yang,2 Po-Chien Shen,2 Yang-Hong Dai,2 Ying-Fu Wang,2 Chun-Shu Lin,2 Wei-Chou Chang,1 Cheng-Hsiang Lo2 1Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Autor:
Wen-Yen Huang, Po-Chien Shen, Cheng-Hsiang Lo, Jen-Fu Yang, Hsing-Lung Chao, Chun-Shu Lin, Ying-Fu Wang, Yang-Hong Dai
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Background Genomic profiles of specific gene sets have been established to guide personalized treatment and prognosis for patients with breast cancer (BC). However, epigenomic information has not yet been applied in a clinical setting. ST14 encodes m
Publikováno v:
Radiotherapy of Liver Cancer ISBN: 9789811618147
Accurate assessment of the response to radiotherapy is essential to avoid missing the opportunity for early salvage treatment for residual tumors as well as overtreatment in complete responders. The evaluation of radiotherapy response in liver tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd1bcf804cfb53a17a1bcd33c3f0fc2
https://doi.org/10.1007/978-981-16-1815-4_19
https://doi.org/10.1007/978-981-16-1815-4_19
Autor:
Cheng-Hsiang Lo, Jenny Y. Que, Po Chien Shen, Jason Chia-Hsien Cheng, Wen Yen Huang, Jen Fu Yang, Chiao Ling Tsai, Yang Hong Dai, Yu Ju Lin, Mei Hsuan Lee
Publikováno v:
Liver Cancer, Pp 1-12 (2020)
Liver Cancer
Liver Cancer
Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment modality for hepatocellular carcinoma (HCC) with promising outcome. However, appropriate survival prediction models are scarce. This study aimed to develop a simple and clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec258910406f78757ea85f6a54da5939
https://www.karger.com/Article/FullText/505693
https://www.karger.com/Article/FullText/505693
Autor:
Yang-Hong Dai, Jen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, Po-Chien Shen, Ying-Fu Wang, Hsing-Lung Chao, Chun-Shu Lin
Publikováno v:
SSRN Electronic Journal.
Background: Radiotherapy has gained increasing attention as an effective cytotoxic agent to improve therapeutic response to immunotherapy. However, synergic effect is seldom seen clinically and reliable biomarkers for optimal patient selection remain